The finance deal26 Jan 2022 14:37
It has been clear all along that exploiting our Paradox Basin reserves will need a lot of capital and that not withstanding the success of the proof of concept well, development would be very slow if we had to rely on cash flow from the PB. Consequently, any plausible growth strategy has to involve either raising more equity capital or finding a partner. Given the need to provide an incentive to new shareholders some dilution of the stake held in the company by existing shareholders is therefore inevitable. In this respect Zephyr is simply in the same position as any other company that has profitable opportunities that cannot be funded from cash flow.
In this instance, the funds are clearly going to be profitably deployed and the loan element of the funding package is on much better terms than many that I have seen offered to small oil companies in the past. What I find more difficult to get a handle on is the dilution implied by our lower share price. We can clearly ignore the briefly available 8p plus share price as being a spike caused by the inevitable tendency of AIM to overreact to news in both directions. Similarly some of the recent fall in the share price will reflect the general market weakness due to considerations such as Covid and the Ukrainian situation. All that said, if purely for example, we assume that without the new share issue the price might be say about 6.5p then the cost of the deal to any shareholder needing to sell now is not trivial. I say for example, simply because I do not know of a reliable way of separating out market wide issues from company specific issues in our case. On a positive note the fact that the price has so far held above 5p implies that the market sees merit in the deal. As others have pointed out, other things being equal the CPR and some positive quarterly reports will help to rebuild the share price before speculative buying starts in a big away ahead of drilling in the second half of 2022.